Common genomic variants associated with variation in plasma lipoproteins in young Aboriginal Canadians

被引:61
作者
Hegele, RA
Connelly, PW
Hanley, AJG
Sun, F
Harris, SB
Zinman, B
机构
[1] UNIV TORONTO, SAMUEL LUNENFELD RES INST, TORONTO, ON, CANADA
[2] UNIV TORONTO, MT SINAI HOSP, TORONTO, ON, CANADA
[3] UNIV WESTERN ONTARIO, THAMES VALLEY FAMILY PRACTICE RES UNIT, LONDON, ON, CANADA
关键词
apolipoproteins; fatty acid-binding protein; hyperlipidemia; paraoxonase; small effects; polygenic traits;
D O I
10.1161/01.ATV.17.6.1060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that common genomic variants would be associated with variation in lipoprotein phenotypes in young subjects. We determined genotypes of FABP2, PON, APOC3, and APOE in 188 aboriginal Canadians, aged 9 to 17 years. We found that 13 of 32 possible genotype-phenotype associations were significant: (1) the FABP2 codon 54 genotype was associated with variation in plasma triglycerides (P=.045): (2) the PON codon 192 genotype was associated with variation in plasma total and LDL cholesterol and apoB (P=.0099, P=.0088, and P=.016, respectively); (3) the APOC3 insulin-response-element genotype was associated with variation in plasma triglycerides, HDL cholesterol, apoA-I, the total cholesterol to HDL cholesterol ratio, and the apoB to apoA-I ratio (P=.0014, P=.0069, P=.045, P=.0021, and P=.0081, respectively); and (4) the APOE restriction isotype was associated with variation in plasma LDL cholesterol, apoB, the total cholesterol to HDL cholesterol ratio, and the apoB to apoA-I ratio (P=.025, P=.034, P=.045, and P=.047, respectively). The average young age and relative absence of age-dependent secondary environmental factors could have eased the identification of small genetic effects on lipoprotein phenotypes in this study sample.
引用
收藏
页码:1060 / 1066
页数:7
相关论文
共 36 条
  • [21] Mehrabian M, 1992, MOL GENETICS CORONAR, P363
  • [22] EVIDENCE FOR LINKAGE OF POSTCHALLENGE INSULIN LEVELS WITH INTESTINAL FATTY-ACID-BINDING PROTEIN (FABP2) IN MEXICAN-AMERICANS
    MITCHELL, BD
    KAMMERER, CM
    OCONNELL, P
    HARRISON, CR
    MANIRE, M
    SHIPMAN, P
    MOYER, MP
    STERN, MP
    FRAZIER, ML
    [J]. DIABETES, 1995, 44 (09) : 1046 - 1053
  • [23] NUNEZ C, 1994, INT J OBESITY, V18, pP498
  • [24] PESONEN E, 1993, EUR HEART J, V14, P7
  • [25] DEOXYRIBONUCLEIC-ACID POLYMORPHISM IN THE APOLIPOPROTEIN-A-1-C-III GENE-CLUSTER - ASSOCIATION WITH HYPERTRIGLYCERIDEMIA
    REES, A
    STOCKS, J
    SHARPE, CR
    VELLA, MA
    SHOULDERS, CC
    KATZ, J
    JOWETT, NI
    BARALLE, FE
    GALTON, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (03) : 1090 - 1095
  • [26] GLN-ARG192 POLYMORPHISM OF PARAOXONASE AND CORONARY HEART-DISEASE IN TYPE-2 DIABETES
    RUIZ, J
    BLANCHE, H
    JAMES, RW
    GARIN, MCB
    VAISSE, C
    CHARPENTIER, G
    COHEN, N
    MORABIA, A
    PASSA, P
    FROGUEL, P
    [J]. LANCET, 1995, 346 (8979) : 869 - 872
  • [27] SAHA N, 1991, CLIN GENET, V40, P277
  • [28] SAS Institute Inc, 1990, SAS STAT US GUID VER
  • [29] A variant of human paraoxonase arylesterase (HUMPONA) gene is a risk factor for coronary artery disease
    Serrato, M
    Marian, AJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) : 3005 - 3008
  • [30] SING CF, 1985, AM J HUM GENET, V37, P268